Evidence map›Paper›PMID 31156620›Full record

ArticleFrontiers in immunology2019

IRF1 Maintains Optimal Constitutive Expression of Antiviral Genes and Regulates the Early Antiviral Response.

Debasis Panda, Erisa Gjinaj, Mahesh Bachu, Erica Squire, Hilary Novatt, Keiko Ozato, Ronald L Rabin

Open access · goldAbstract read
In one paragraph

Article in Frontiers in immunology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 77 papers.

0numbers the graph read from it
0cells of the map it votes in
77citing papers in PubMed
5.2field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

77 citing papers in PubMed, 109 citations in OpenAlex.

  1. Trial
  2. COJournal of molecular histology · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Intrinsic OASL expression governs heterogeneity in interferon induction during influenza A virus infection.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  13. Article
  14. Article
  15. Article
  16. Interferon-Based Therapeutics in Cancer Therapy: Past, Present, and Future.International journal of molecular sciences · 2025
    Review
  17. Article
  18. Article
  19. Integrative omics and multi-cohort identifyJournal of biomedical research · 2025
    Article
  20. Review

17 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Debasis PandaCenter for Biologics Evaluation and Research, US Food and Drug Administration, Silver Spring, MD, United States.
Erisa GjinajCenter for Biologics Evaluation and Research, US Food and Drug Administration, Silver Spring, MD, United States.
Mahesh BachuEunice Kennedy Shriver National Institute of Child Health and Human Development, Bethesda, MD, United States.
Erica SquireCenter for Biologics Evaluation and Research, US Food and Drug Administration, Silver Spring, MD, United States.
Hilary NovattCenter for Biologics Evaluation and Research, US Food and Drug Administration, Silver Spring, MD, United States.
Keiko OzatoEunice Kennedy Shriver National Institute of Child Health and Human Development, Bethesda, MD, United States.
Ronald L RabinCenter for Biologics Evaluation and Research, US Food and Drug Administration, Silver Spring, MD, United States.
United States Food and Drug Administration · USCenter for Biologics Evaluation and Research · USEunice Kennedy Shriver National Institute of Child Health and Human Development · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Viral defense at mucosal sites depends on interferons (IFN) and IFN stimulated genes (ISGs), either of which may be constitutively expressed to maintain an "antiviral state" (AVS). However, the mechanisms that govern the AVS are poorly defined. Using a BEAS-2B respiratory epithelial cell line deficient in IRF1, we demonstrate higher susceptibility to infection with vesicular stomatitis virus (VSV) and influenza virus. IRF1-mediated restriction of VSV is IFN-independent, as blockade of types I and III IFNs and JAK-STAT signaling before infection did not affect VSV infection of either parent or IRF1 KO cells. Transcriptome analysis revealed that IRF1 regulates constitutive expression of ~300 genes, including antiviral ISGs:

Indexed as

2',5'-Oligoadenylate SynthetaseA549 CellsAntigens, CDBone Marrow Stromal Antigen 2EndoribonucleasesEpithelial CellsGene Expression RegulationGene Knockout TechniquesGPI-Linked ProteinsHumansInfluenza, HumanInterferon Regulatory Factor-1InterferonsOrthomyxoviridaeRespiratory MucosaRhabdoviridae Infections2-5A-dependent ribonuclease2',5'-Oligoadenylate SynthetaseAntigens, CDBone Marrow Stromal Antigen 2BST2 protein, humanEndoribonucleasesGPI-Linked ProteinsInterferon Regulatory Factor-1InterferonsIRF1 protein, humanOAS2 protein, humanToll-Like Receptorsantiviral statebasal defense responseepigenetic regulationinterferon independenttranscription factor

Identifiers

PMID31156620
PMCPMC6529937
OpenAlexW2945865759

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.